VALERIO THERAPEUTICS: List of the Board Members Positions Held in Other Companies as of March 19, 2025 [Yahoo! Finance]
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock.
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)